Eli Lilly’s stock falls after fake blue-check tweet

Share post:

Eli Lilly’s stock fell millions in a single day to $14 billion, all thanks to a fake “verified” account on Elon Musk’s new Twitter payment system.

That account impersonated Eli Lilly and tweeted “insulin is free now,” implying that the pharmaceutical company’s insulin would soon be free.

Other Health care stocks such as Novo Nordisk and Sanofi also came under pressure on Friday, with Novo Nordisk shares falling 3.5% to 111.47 and Sanofi’s losing 3.4% to finish the regular session at 42.80, possibly in solidarity with Eli Lilly.

Although the account was quickly suspended, the damage had already been done, as worried shareholders confused it with reality and sold shares at a rapid pace.

Twitter’s disinformation problem is exacerbated by the democratization of the Blue Check, which has since been halted. Several corporate and government imposters targeted Eli Lilly and Company, including fake accounts for defense manufacturer Lockheed Martin, oil company BP, and produce distributor Chiquita.

The sources for this piece include an article in Investors.com.

SUBSCRIBE NOW

Related articles

Spotify CEO confesses to “rough times after layoffs” – stock price rises

In December, Spotify CEO Daniel Ek announced the largest round of layoffs in the company's history, cutting 1,500...

Zuckerberg shares his vision with investors and Meta stock tanks

In an era where instant gratification is often the norm, Meta CEO Mark Zuckerberg’s strategic pivot towards long-term,...

Apple reduces forecasts for Vision Pro as demand cools in key US market

In an unexpected shift, Apple has drastically reduced its shipment forecasts for the upcoming Vision Pro, indicating a...

FTC says Microsoft’s layoffs at Activision Blizzard may threaten merger approval

The FTC has expressed dissatisfaction with Microsoft's layoffs at Activision Blizzard, challenging the integrity of the Microsoft-Activision deal....

Become a member

New, Relevant Tech Stories. Our article selection is done by industry professionals. Our writers summarize them to give you the key takeaways